Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
-
Dr. Michael Kelley National Program Director for Oncology VA -
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
HHS Accelerates AI, TEFCA in 2024
Micky Tripathi, tech policy and health IT leader, reflects on progress HHS has made with AI, data and TEFCA and outlines plans for 2025.
-
Library of Congress, NARA Modernize Records Management with Emerging Tech
Natalie Buda Smith and Jill Reilly dive into the challenges of preserving and providing access to digital-native materials.
19m listen -
VA Focuses on Continuous Improvement for 2026 EHR Rollout
VA plans to resume rollout of its EHR in mid-2026, focusing recent feedback to drive continuous improvement amid the presidential transition.
4m read -
DHS Leads Government’s Largest Civilian AI Hiring Effort
On this AI GovCast miniseries, Boyce discusses his journey to the agency with his prior roles at the Office of Management and Budget.
15m listen
